Objective: To retrospectively compare portal venous phase (PVP) and delayed phase (DP) for the detection of tumor washout at gadobenate dimeglumineYenhanced liver magnetic resonance imaging (MRI) in cirrhotic patients with hypervascular hepatocellular carcinoma (HCC). Methods: Thirty-three patients with 55 HCCs underwent 1.5-T MRI by means of fat-suppressed T1-weighted sequence obtained before and after gadobenate dimeglumine administration, during early and late arterial phases, PVP (70 seconds), and DP (180 seconds). Detection rates of contrast washout of hypervascular HCCs and tumor-to-liver contrast on PVP and DP were measured and compared. Results: Among 54 hypervascular HCCs, washout was present in 24 (44%) of 54 tumors on PVP and in ...
BACKGROUND: Characterization of small nodules in the cirrhotic liver is always challenging in clinic...
PURPOSE: To evaluate hepatobiliary phase magnetic resonance imaging with gadobenate dimeglumine f...
Purpose: To compare the level of parenchymal and portal venous enhancement in the portal venous phas...
OBJECTIVES: Our aim was to compare retrospectively hepatic venous and delayed phase images for the ...
OBJECTIVES: Our aim was to compare retrospectively hepatic venous and delayed phase images for the d...
OBJECTIVES: To evaluate the value of 1-hour delayed phase imaging (DPI) of gadobenate dimeglumine (G...
Purpose: To compare the image quality and diagnostic performance of 1- and 3-h delayed-phase MR imag...
Objectives: Our aim was to compare retrospectively hepatic venous and delayed phase images for the d...
PURPOSE: To compare two different injection rates for gadoxetic acid-enhanced hepatic arterial phase...
Objective: The purpose of the study was to determine if the gadoxetic acid-enhanced magnetic resonan...
Objective: To intraindividually compare hepatocellular carcinoma (HCC) washout between MRIs using he...
OBJECTIVE: To compare the value of diffusion-weighted MRI (DWI) with the venous "washout" appearance...
Purpose: To prospectively investigate whether combined interpretation of dynamic and hepatobiliary p...
PURPOSE: We evaluated whether the addition of delayed phase imaging (DPI) gadobenate dimeglumine-enh...
Purpose: To retrospectively compare the perfusion parameters of advanced hepatocellular carcinoma (H...
BACKGROUND: Characterization of small nodules in the cirrhotic liver is always challenging in clinic...
PURPOSE: To evaluate hepatobiliary phase magnetic resonance imaging with gadobenate dimeglumine f...
Purpose: To compare the level of parenchymal and portal venous enhancement in the portal venous phas...
OBJECTIVES: Our aim was to compare retrospectively hepatic venous and delayed phase images for the ...
OBJECTIVES: Our aim was to compare retrospectively hepatic venous and delayed phase images for the d...
OBJECTIVES: To evaluate the value of 1-hour delayed phase imaging (DPI) of gadobenate dimeglumine (G...
Purpose: To compare the image quality and diagnostic performance of 1- and 3-h delayed-phase MR imag...
Objectives: Our aim was to compare retrospectively hepatic venous and delayed phase images for the d...
PURPOSE: To compare two different injection rates for gadoxetic acid-enhanced hepatic arterial phase...
Objective: The purpose of the study was to determine if the gadoxetic acid-enhanced magnetic resonan...
Objective: To intraindividually compare hepatocellular carcinoma (HCC) washout between MRIs using he...
OBJECTIVE: To compare the value of diffusion-weighted MRI (DWI) with the venous "washout" appearance...
Purpose: To prospectively investigate whether combined interpretation of dynamic and hepatobiliary p...
PURPOSE: We evaluated whether the addition of delayed phase imaging (DPI) gadobenate dimeglumine-enh...
Purpose: To retrospectively compare the perfusion parameters of advanced hepatocellular carcinoma (H...
BACKGROUND: Characterization of small nodules in the cirrhotic liver is always challenging in clinic...
PURPOSE: To evaluate hepatobiliary phase magnetic resonance imaging with gadobenate dimeglumine f...
Purpose: To compare the level of parenchymal and portal venous enhancement in the portal venous phas...